---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-26-000013"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2026-05-13T20:35:45+00:00"
generated_at: "2026-05-13T20:40:20.800641+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Prestige Consumer reports FY26 adj EPS $4.38; acquires LaCorium Health for $150M

## Summary
- FY26 revenue $1,088.7M (-4.3% YoY); adjusted diluted EPS $4.38 vs $4.52 prior year.
- Q4 revenue $281.6M (-5% YoY); adjusted diluted EPS $1.23 vs $1.32.
- Acquiring LaCorium Health (Australian therapeutic skincare) for ~$150M cash; expected close Q2 FY27.
- LaCorium TTM revenue ~$40M; expected ~$12M EBITDA with synergies.
- FY27 outlook: organic revenue growth 1-3%, adj EPS $4.42-$4.51, FCF $250M+.

## SEC filing metadata
- accession: 0001295947-26-000013
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2026-05-13T20:35:45+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594726000013/0001295947-26-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594726000013/pbh-20260513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-26-000013
- JSON: https://secwatch.observer/filing/0001295947-26-000013.json
- Plain text: https://secwatch.observer/filing/0001295947-26-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.